IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,030,000 | +13.6% | 52,929 | -2.8% | 0.00% | 0.0% |
| Q4 2017 | $907,000 | -18.0% | 54,455 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,106,000 | +26.4% | 54,455 | +0.1% | 0.00% | 0.0% |
| Q2 2017 | $875,000 | +28.5% | 54,383 | +0.9% | 0.00% | 0.0% |
| Q1 2017 | $681,000 | +40.4% | 53,874 | +60.4% | 0.00% | 0.0% |
| Q4 2016 | $485,000 | -70.5% | 33,586 | -51.6% | 0.00% | -50.0% |
| Q3 2016 | $1,643,000 | -5.5% | 69,343 | +15.0% | 0.00% | 0.0% |
| Q2 2016 | $1,738,000 | -11.3% | 60,298 | -1.4% | 0.00% | 0.0% |
| Q1 2016 | $1,959,000 | -25.8% | 61,181 | -0.9% | 0.00% | -33.3% |
| Q4 2015 | $2,640,000 | +18.0% | 61,733 | -2.9% | 0.00% | 0.0% |
| Q3 2015 | $2,237,000 | +176.2% | 63,546 | +260.0% | 0.00% | +200.0% |
| Q2 2015 | $810,000 | +22.9% | 17,652 | +25.5% | 0.00% | 0.0% |
| Q1 2015 | $659,000 | +8.4% | 14,067 | -26.7% | 0.00% | 0.0% |
| Q4 2014 | $608,000 | -37.2% | 19,181 | -53.0% | 0.00% | 0.0% |
| Q3 2014 | $968,000 | -33.8% | 40,803 | -16.3% | 0.00% | -50.0% |
| Q2 2014 | $1,462,000 | +7.7% | 48,741 | -5.2% | 0.00% | 0.0% |
| Q1 2014 | $1,357,000 | -67.1% | 51,405 | -68.7% | 0.00% | -66.7% |
| Q4 2013 | $4,130,000 | +22.8% | 164,308 | 0.0% | 0.01% | +20.0% |
| Q3 2013 | $3,363,000 | -37.1% | 164,308 | -38.7% | 0.01% | -44.4% |
| Q2 2013 | $5,347,000 | – | 268,139 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |